SOL vs. AIP, WOLF, IPAX, MVIS, NNDM, CAN, TBCH, AUDC, ALMU, and LPTH
Should you be buying Emeren Group stock or one of its competitors? The main competitors of Emeren Group include Arteris (AIP), Wolfspeed (WOLF), Inflection Point Acquisition (IPAX), Microvision (MVIS), Nano Dimension (NNDM), Canaan (CAN), Turtle Beach (TBCH), AudioCodes (AUDC), Aeluma (ALMU), and LightPath Technologies (LPTH). These companies are all part of the "electronic equipment" industry.
Emeren Group vs. Its Competitors
Arteris (NASDAQ:AIP) and Emeren Group (NYSE:SOL) are both small-cap electronic equipment companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends.
Arteris has a beta of 1.44, indicating that its stock price is 44% more volatile than the S&P 500. Comparatively, Emeren Group has a beta of 2.01, indicating that its stock price is 101% more volatile than the S&P 500.
Emeren Group has higher revenue and earnings than Arteris. Emeren Group is trading at a lower price-to-earnings ratio than Arteris, indicating that it is currently the more affordable of the two stocks.
Emeren Group has a net margin of -5.77% compared to Arteris' net margin of -52.41%. Emeren Group's return on equity of -1.16% beat Arteris' return on equity.
64.4% of Arteris shares are held by institutional investors. Comparatively, 44.1% of Emeren Group shares are held by institutional investors. 29.1% of Arteris shares are held by company insiders. Comparatively, 37.3% of Emeren Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Arteris had 4 more articles in the media than Emeren Group. MarketBeat recorded 8 mentions for Arteris and 4 mentions for Emeren Group. Arteris' average media sentiment score of 0.90 beat Emeren Group's score of 0.36 indicating that Arteris is being referred to more favorably in the media.
Arteris presently has a consensus target price of $15.00, suggesting a potential upside of 49.70%. Emeren Group has a consensus target price of $5.00, suggesting a potential upside of 165.25%. Given Emeren Group's higher possible upside, analysts clearly believe Emeren Group is more favorable than Arteris.
Summary
Emeren Group beats Arteris on 9 of the 16 factors compared between the two stocks.
Get Emeren Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for SOL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SOL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Emeren Group Competitors List
Related Companies and Tools
This page (NYSE:SOL) was last updated on 9/19/2025 by MarketBeat.com Staff